Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro.
Journal of thrombosis and haemostasis : JTH·2018
Clot waveform analysis using CS-2000i™ distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia·2017
Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow-chamber system.
Journal of thrombosis and haemostasis : JTH·2016
Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity.
Journal of thrombosis and haemostasis : JTH·2015
Systematic monitoring of hemostatic management in hemophilia A patients with inhibitor in the perioperative period using rotational thromboelastometry.
Journal of thrombosis and haemostasis : JTH·2015
Activated prothrombin complex concentrate (APCC)-mediated activation of factor (F)VIII in mixtures of FVIII and APCC enhances hemostatic effectiveness.
Journal of thrombosis and haemostasis : JTH·2013
[Hemophagocytic syndrome associated with hypercytokinemia in a patients with rheumatoid arthritis].
Ryumachi. [Rheumatism]·2003
[Case of vascular Behçet's disease initially presented with Bürger's disease-like vasculitides].
Ryumachi. [Rheumatism]·2003
[A case of psoriatic arthropathy complicated with HTLV-I carrier and secondary amyloidosis].
Ryumachi. [Rheumatism]·2003
[HIV-associated myopathy: a case report].
The Pan African medical journal·2026
SOHO State of the Art Updates and Next Questions| Mediastinal Gray-zone Lymphoma: Novel Biologic Insights and Updates on How Best to Approach This Rare Entity.
Clinical lymphoma, myeloma & leukemia·2026
Exploring the relationship between natural and cryptic polyreactivity in human antibodies.
Molecular immunology·2026